The study is being conducted by the U.S. based company Bioheart which has assembled teams of doctors and specialists specially trained in stem cell therapies. Based on previous treatment of Type 2 diabetes with autologous stem cells, it is estimated that two-thirds of participants will experience a significant improvement in their daily lives and great symptom reduction.
“With stem cell treatment rapidly coming to the forefront of 21st Century medicine, we are pleased that Type 2 Diabetes is among the many chronic conditions that are treatable with adult stem cells rather than potentially risky surgery, dangerous transplants, and toxic drugs.” said RSCI founder and Chairman Don Margolis in a recent interview.
Who is eligible ?
Any patient with diabetes type-2 is free to apply for participation
About the treatment
The procedure will be performed in a participating doctor’s office as a point-of-care out-patient. The procedure will be carried out in 4-stages:
- Adipose Harvest: During a 3 to 5 hour visit to the doctor’s office, a mini-liposuction the stomach will be used to extract a small amount of adipose tissue, containing tens of millions of adipose (fat) stem cells.
- Laboratory Processing: The extracted stem cells will be isolated, analyzed, cleaned and concentrated.
- Stem Cell Implantation: Up to 60 million stem cells will be transplanted intravenously, most probably into the arm. Because the cells are autologous (the patient’s own), the risk of rejection is minimal.
- Postoperative Care: Normally, the participant will leave shortly after the implantation. RSCI will check his progress on a monthly basis, by telephone for the first year after the stem cell treatment.
The cost for each participant, including all treatments and follow-up care, is $5,000. The same procedure can be done any time at competent stem cell treatment centers worldwide, but costsmay be increased, sometimes double.
Instruction for participating Those interested to participate in the trial should contact the RSCI as soon as possible since participation is limited to 100 Type-2 Diabetes patients. Those who apply first get their pick of treatment dates.
For more information about the trial and adult stem cell therapy in general please visit the Repair Stem Cells Institute website.
Repair Stem Cells Institute
3010 LBJ Freeway, Suite 1200
Dallas, TX 75234
Tel: (214) 556-6377
Diabetes mellitus type 2 is a metabolic disorder that is characterized by hyperglycemia (high blood sugar) in the context of insulin resistance and relative lack of insulin. This is in contrast to diabetes mellitus type 1, in which there is an absolute lack of insulin due to breakdown of islet cells in the pancreas. The classic symptoms are excess thirst, frequent urination, and constant hunger. Type 2 diabetes makes up about 90% of cases of diabetes, with the other 10% due primarily to diabetes mellitus type 1 and gestational diabetes. Obesity is thought to be the primary cause of type 2 diabetes in people who are genetically predisposed to the disease.